We undertook a randomized trial (ClinicalTrials.gov Identifier: NCT01418859) to compare the efficacy and toxicity of concurrent chemoradiotherapy with topotecan and cisplatin with radiotherapy alone in intermediate-risk cervical cancer patients.
Twenty-eight mild, atopic asthmatic subjects were recruited for a double-blind, randomized, placebo-controlled, parallel-group trial (ClinicalTrials.gov identifier NCT00983658) to compare blockade of OX40L using a humanized anti-OX40L MAb to placebo-administered intravenously in 4 doses over 3 months.
The subjects included in this study were the first 105 subjects enrolled in a multisite randomized clinical trial (ClinicalTrials.gov identifier: NCT01362686) to compare the tolerability of AChEIs in older adults with a diagnosis of AD. 23 The study enrolled patients cared for in a memory care practice from one of four health care systems within the Indianapolis Discovery Network for Dementia.
12 This was a prospective, multicentre (36 sites in the USA), double-masked, randomised, parallel-group, 12-week study (ClinicalTrials.gov Identifier: NCT01099774) to compare the efficacy and safety of new PF bimatoprost 0.03% ophthalmic solution (bimatoprost PF) and bimatoprost 0.03% ophthalmic solution (bimatoprost) administered once daily for 12 weeks in patients with OHT or glaucoma.
The LIFE Study is a Phase III multicenter RCT (Clinical-Trials.gov identifier NCT01072500) designed to compare a moderate-intensity PA program with SA to assess effects on major mobility disability, defined as inability to walk 400 m.
18 Therefore, we initiated the ROBOT trial (ClinicalTrial.gov identifier: NCT01544790) in January 2012 to compare RAMIE with open transthoracic esophagectomy.
We decided to compare InChI identifiers directly, because the back conversion is not fully reliable (see Appendix B for details).
Apart from being comprehensive and relatively up-to-date, the main contribution of iRefIndex is in addressing the problem of protein identifiers by mapping the sequence of every interactant into a unique identifier that can be used to compare interactants from different source databases.
In order to compare proteins identified by SILAC with mRNAs shifted to polysomes, the IPI identifiers (Kersey et al., 2004) from the SILAC experiment were mapped to the RefSeq identifiers used for the RNA-seq data.
Since there were no student identifiers on the exams, it was not possible to compare the characteristics of the two groups.
